Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Vaccines”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Not applicableEnded earlyNCT02766088
What this trial is testing

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Who this might be right for
DengueDengue Vaccines
GlaxoSmithKline 1,750
Large-scale testing (Phase 3)Study completedNCT03423173
What this trial is testing

Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue

Who this might be right for
Dengue Fever
Takeda 923
Not applicableActive Not RecruitingNCT04113330
What this trial is testing

Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia

Who this might be right for
Dengue Fever
Sanofi Pasteur, a Sanofi Company 918
Testing effectiveness (Phase 2)Study completedNCT00880893
What this trial is testing

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus+1 more
Sanofi Pasteur, a Sanofi Company 1,198
Early research (Phase 1)Study completedNCT01702857
What this trial is testing

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)

Who this might be right for
Dengue Fever
U.S. Army Medical Research and Development Command 100
Large-scale testing (Phase 3)Study completedNCT03341637
What this trial is testing

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Who this might be right for
Dengue
Takeda 400
Early research (Phase 1)Study completedNCT02887482
What this trial is testing

GLS-5700 in Dengue Virus Seropositive Adults

Who this might be right for
HealthyZika
GeneOne Life Science, Inc. 160
Large-scale testing (Phase 3)Study completedNCT06060067
What this trial is testing

Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Who this might be right for
Healthy Volunteers
Takeda 480
Early research (Phase 1)Study completedNCT04786457
What this trial is testing

ADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)

Who this might be right for
Dengue
University of Maryland, Baltimore 10
Not applicableStudy completedNCT06418854
What this trial is testing

Dengue Vaccine Hesitancy Among International Travelers

Who this might be right for
Vaccine Hesitancy
Mahidol University 390
Testing effectiveness (Phase 2)Study completedNCT05710224
What this trial is testing

Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)

Who this might be right for
Dengue
Butantan Institute 1,364
Early research (Phase 1)Study completedNCT02021968
What this trial is testing

Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 48
Very early researchStudy completedNCT06837116
What this trial is testing

Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers

Who this might be right for
Dengue
Prince of Songkla University 29
Testing effectiveness (Phase 2)Study completedNCT02628444
What this trial is testing

Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of Age

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 1,050
Not applicableActive Not RecruitingNCT06898775
What this trial is testing

Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.

Who this might be right for
Dengue Vaccines
Fundación Vacunar 112,345
Large-scale testing (Phase 3)Study completedNCT02993757
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Papillomavirus Disease
Sanofi Pasteur, a Sanofi Company 528
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT03803618
What this trial is testing

Dengue Effectiveness Study in the Philippines

Who this might be right for
DengueSevere DengueVirologically Confirmed Dengue
University of the Philippines 2,081
Large-scale testing (Phase 3)Looking for participantsNCT06665035
What this trial is testing

2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

Who this might be right for
Dengue Fever
Takeda 212
Early research (Phase 1)UnknownNCT03141138
What this trial is testing

Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine

Who this might be right for
Dengue Virus
U.S. Army Medical Research and Development Command 40
Load More Results